DengiAll will be the first indigenous single-shot dengue vaccine in India and is expected to enter the markets by 2027
With milestone-linked funding of Rs. 5–25 crore per project (and up to Rs. 50 crore in exceptional cases), the Mission will support projects that bring impactful MedTech solutions to market
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
ICMR will continue to track trends in HMPV circulation throughout the year
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
The clinical trial will be conducted at 19 sites with 10,335 participants across India
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
Launch of Indian public health standards for Ayush healthcare facilities
Science communication brings behavioural changes
Subscribe To Our Newsletter & Stay Updated
